Merck Serono Australia has
launched a new “patient support
program” (PSP) for first line
access to its Erbitux treatment for
metastatic colorectal cancer.
Under the program Merck
Serono will pay for every second
treatment using Erbitux, and once
the patient contribution reaches
$16,000 Merck will pay for every
subsequent treatment.
Erbitux will be ordered through,
and shipped directly to, the
patient’s nominated pharmacy for
dispensing and the pharmacy will
be charged at the price of $400 per
100mg/20mL vial.
The medication must be ordered
and purchased directly from Merck
Serono Australia Customer Service.
The PSP will be available from 01
Jun-31 Dec 2013.
For details ring Merck Serono
medicines info on 1800 633 463.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Sep 13
PATIENTS who legitimately need compounded Ozempic should still have access to the medication, even if a government ban comes into effect, advises the Consumers Health Forum of Australia (CHF).
QUEENSLAND pharmacists can commence their full scope of practice journey with the newly launched Prescribing Hormonal Contraceptives Course by the Australasian College of Pharmacy.
A SURGE in international and local demand has led to complementary medicines becoming a huge success story for Australia, according to peak body Complementary Medicines Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.